| 0 (0%) | 11-11 15:57 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | |
|||
| Targets | 6-month : | 13.53 | 1-year : | 13.79 |
| Resists | First : | 11.58 | Second : | 11.81 |
| Pivot price | 11.3 | |||
| Supports | First : | 11.22 | Second : | 9.33 |
| MAs | MA(5) : | 11.3 | MA(20) : | 11.3 |
| MA(100) : | 11.46 |
MA(250) : | 10.47 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 13.5 | D(3) : | 13.5 |
| RSI | RSI(14): 41.7 | |||
| 52-week | High : | 12.5 | Low : | 7.53 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ ESXB ] has closed Bollinger Bands are 100% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 39 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
Tue, 13 Aug 2024
The regulatory functions of ESX-1 substrates, EspE and EspF, are separable from secretion - ASM Journals
Fri, 29 Mar 2024
Mycobacterium tuberculosis inhibits METTL14-mediated m - Nature
Tue, 10 Oct 2023
Three small partner proteins facilitate the type VII-dependent secretion of an antibacterial nuclease - ASM Journals
Fri, 29 Sep 2023
An N-acetyltransferase required for ESAT-6 N-terminal acetylation and virulence in Mycobacterium marinum - ASM Journals
Thu, 23 Mar 2023
ATG7 and ATG14 restrict cytosolic and phagosomal Mycobacterium tuberculosis replication in human macrophages - Nature
Mon, 06 Dec 2021
United Bank closes $303M acquisition - The Business Journals
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 22 (M) |
| Shares Float | 22 (M) |
| Held by Insiders | 3.2 (%) |
| Held by Institutions | 56.2 (%) |
| Shares Short | 25 (K) |
| Shares Short P.Month | 21 (K) |
| EPS | 1.05 |
| EPS Est Next Qtrly | 0.12 |
| EPS Est This Year | 0.49 |
| EPS Est Next Year | 0.56 |
| Book Value (p.s.) | 8.21 |
| Profit Margin | 36.5 % |
| Operating Margin | 47.2 % |
| Return on Assets (ttm) | 1.4 % |
| Return on Equity (ttm) | 13.7 % |
| Qtrly Rev. Growth | 22.7 % |
| Gross Profit (p.s.) | 2.35 |
| Sales Per Share | 2.93 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 45 % |
| Operating Cash Flow | 26 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 10.66 |
| PEG Ratio | 0 |
| Price to Book value | 1.37 |
| Price to Sales | 3.84 |
| Price to Cash Flow | 9.69 |
| Dividend | 0.25 |
| Forward Dividend | 0.28 |
| Dividend Yield | 0% |
| Dividend Pay Date | 2021-12-01 |
| Ex-Dividend Date | 2021-11-25 |